Closing the information gap between clinical and postmarketing trials: the case of dabigatran

Herbert J A Rolden; Janneke P C Grutters; Gert Jan van der Wilt; Angela H E M Maas

doi:10.1093/ehjcvp/pvv020

Closing the information gap between clinical and postmarketing trials: the case of dabigatran

Herbert J A Rolden, Janneke P C Grutters, Gert Jan van der Wilt, Angela H E M Maas

Onderzoeksoutput: Article › Academic › peer review

Originele taal-2	English
Pagina's (van-tot)	153-156
Aantal pagina's	4
Tijdschrift	European heart journal. Cardiovascular pharmacotherapy
Volume	1
Nummer van het tijdschrift	3
DOI's	https://doi.org/10.1093/ehjcvp/pvv020
Status	Published - 17 apr. 2015
Extern gepubliceerd	Ja

Toegang tot document

10.1093/ehjcvp/pvv020

Andere bestanden en links

https://www.mendeley.com/catalogue/f8907123-5ecc-3332-a8d6-12df6fbe3da0/

Citeer dit

@article{948863cb58be4184b2888e2505c8e0db,

title = "Closing the information gap between clinical and postmarketing trials: the case of dabigatran",

keywords = "dabigatran, randomized controlled trial, subgroup analysis, health technology assessment, vitamin K antagonists, postmarketing trials, clinical trials, ethics, medical ethics, effect uncertainty, health care expenses, medicine, cardiovascular disease, randomized controlled trials as topic",

author = "Rolden, {Herbert J A} and Grutters, {Janneke P C} and {van der Wilt}, {Gert Jan} and Maas, {Angela H E M}",

year = "2015",

month = apr,

day = "17",

doi = "10.1093/ehjcvp/pvv020",

language = "English",

volume = "1",

pages = "153--156",

journal = "European heart journal. Cardiovascular pharmacotherapy",

issn = "2055-6845",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Closing the information gap between clinical and postmarketing trials: the case of dabigatran

AU - Rolden, Herbert J A

AU - Grutters, Janneke P C

AU - van der Wilt, Gert Jan

AU - Maas, Angela H E M

PY - 2015/4/17

Y1 - 2015/4/17

KW - dabigatran

KW - randomized controlled trial

KW - subgroup analysis

KW - health technology assessment

KW - vitamin K antagonists

KW - postmarketing trials

KW - clinical trials

KW - ethics

KW - medical ethics

KW - effect uncertainty

KW - health care expenses

KW - medicine

KW - cardiovascular disease

KW - randomized controlled trials as topic

UR - https://www.mendeley.com/catalogue/f8907123-5ecc-3332-a8d6-12df6fbe3da0/

U2 - 10.1093/ehjcvp/pvv020

DO - 10.1093/ehjcvp/pvv020

M3 - Article

C2 - 27533988

SN - 2055-6845

VL - 1

SP - 153

EP - 156

JO - European heart journal. Cardiovascular pharmacotherapy

JF - European heart journal. Cardiovascular pharmacotherapy

IS - 3

ER -